Both in Biotechnology
Eloxx Pharmaceuticals vs Cardiff Oncology
Over the past year ELOX returned −18.7% and CRDF returned −37.6%; their daily moves had a correlation of 0.17.
ELOX −18.7% CRDF −37.6%Growth of $1, one year, split-adjusted
| Metric | ELOX | CRDF |
|---|---|---|
| Price | $12.80 | $0.7553 |
| Market cap | $51.7M | $58.8M |
| Today | +0.47% | −13.07% |
| 1 month | −14.0% | −30.7% |
| 6 months | — | −52.8% |
| Year to date | — | −73.1% |
| 1 year | — | −66.0% |
| Revenue growth (YoY) | — | −14.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −8882.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 115.7× |
| Net cash | $62.0M | $34.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 76.0% |
| Short % of float | 1.3% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).